Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 9, 2026

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
05:19

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

Molecular markers in bladder cancer.

Shahrokh F Shariat1, Jose A Karam, Seth P Lerner

  • 1Department of Urology, UT Southwestern Medical Center, Dallas, Texas 75390-9110, USA. Shahrokh.Shariat@UTSouthwestern.edu

Current Opinion in Urology
|December 20, 2007
PubMed
Summary

Molecular markers are key to understanding bladder cancer. Research into these bladder cancer markers can improve detection, prognosis, and personalized treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma.

The New England journal of medicine·2026
Same author

Divergent biology and outcomes of somatic transformations in germ cell tumors.

The oncologist·2026
Same author

5x-Multiplier Versus 3-Tier Model: A Pragmatic Randomized Clinical Trial for Discharge Opioid Prescriptions After Intra-Abdominal Cancer Surgery.

Annals of surgery·2026
Same author

Renal Medullary Carcinoma: Utility of [<sup>18</sup>F]FDG PET/CT in Evaluating Extent of Disease and Impact on Treatment Management.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026
Same author

Beyond Clear Cell: Rethinking Postoperative Surveillance for Non-clear Cell Renal Cell Carcinoma Subtypes.

European urology oncology·2026
Same author

Comprehensive Genomic and Transcriptomic Characterization of Matched Primary and Recurrent Tumors in High-risk Localized Renal Cell Carcinoma.

European urology·2026

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Bladder cancer exhibits diverse molecular phenotypes.
  • Understanding these phenotypes is crucial for effective management.

Purpose of the Study:

  • To review current molecular pathways and markers in bladder cancer.
  • To highlight recent advancements in marker discovery and application.

Main Methods:

  • Review of existing literature on molecular bladder cancer research.
  • Analysis of genetic and epigenetic aberrations.
  • Investigation of cell cycle, apoptotic, and angiogenic pathways.

Main Results:

  • Genetic and epigenetic alterations are linked to bladder cancer pathogenesis and prognosis.

More Related Videos

Cell-Free DNA Integrity Analysis in Urine Samples
07:58

Cell-Free DNA Integrity Analysis in Urine Samples

Published on: January 5, 2017

Related Experiment Videos

Last Updated: Jul 9, 2026

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
05:19

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

Cell-Free DNA Integrity Analysis in Urine Samples
07:58

Cell-Free DNA Integrity Analysis in Urine Samples

Published on: January 5, 2017

  • Cell cycle markers are well-studied; apoptotic and angiogenic pathways are emerging areas.
  • Concurrent analysis of multiple molecular alterations enhances prognostic accuracy.

    • Conclusions:

    • Molecular insights are fundamental to understanding bladder cancer.
    • New marker discovery and pathway analysis are essential.
    • Molecular markers offer potential for improved bladder cancer detection, prognosis, and personalized treatment.